Aneurysmal subarachnoid hemorrhage: An update on the medical complications and treatments strategies seen in these patients

Current Opinion in Anaesthesiology

Volumn 24, Issue 5, 2011, Pages 500-507

  Rose, Margaret J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cerebral aneurysm; hypotonic hypervolemic hypertensive therapy; neurogenic myocardial dysfunction; subarachnoid hemorrhage

Indexed keywords

AMINOCAPROIC ACID; ANTICONVULSIVE AGENT; ANTIFIBRINOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM;

ANEMIA; ANEURYSM RUPTURE; ANTICONVULSANT THERAPY; BRAIN HERNIA; BRAIN ISCHEMIA; BRAIN VASOSPASM; CEREBRAL SALT WASTING; CLINICAL ASSESSMENT TOOL; DISEASE CLASSIFICATION; DIURETIC THERAPY; FEVER; FISHER SCALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEMODILUTION; HESS SCALE; HORMONAL THERAPY; HUMAN; HUNT SCALE; HYPERTENSION; HYPERVOLEMIC HYPERTENSIVE HEMODILUTION THERAPY; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRACRANIAL PRESSURE MONITORING; LUNG EDEMA; META ANALYSIS (TOPIC); MYOCARDIAL DISEASE; NEUROPROTECTION; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; SUBARACHNOID HEMORRHAGE;

BIOLOGICAL MARKERS; BRAIN; BRAIN ISCHEMIA; HUMANS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 80052649472     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32834ad45b     Document Type: Review

References (71)

1. le Roux AA, Wallace MC. Outcome and cost of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21:235-246.
2. Nieuwkamp DJ, Algra A, Blomqvist P, et al. Excess mortality and cardiovascular events in patients surviving subarachnoid hemorrhage: a nationwide study in sweden. Stroke 2011; 42:902-907.
3. de Rooij NK, Linn FH, van der Plas JA, et al. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007; 78:1365-1372. (Pubitemid 350221419)
4. Zacharia BE, Hickman ZL, Grobelny BT, et al. Epidemiology of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21:221-233.
5. Lindekleiv H, Sandvei MS, Njolstad I, et al. Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: a cohort study. Neurology 2011; 76:637-643.
6. Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology 2010; 74:1494-1501.
7. Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21:325-338.
8. Wartenberg KE. Critical care of poor-grade subarachnoid hemorrhage. Curr Opin Crit Care 2011; 17:85-93.
9. Hoff RG, Rinkel GJ, Verweij BH, et al. Pulmonary edema and blood volume after aneurysmal subarachnoid hemorrhage: a prospective observational study. Crit Care 2010; 14:R43.
10. Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: a systematic review. Neurocritical care 2005; 2:110-118. (Pubitemid 41270853)
11. Sehba FA, Pluta RM, Zhang JH. Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 2011; 43:27-40.
12. Skoglund K, Enblad P, Marklund N. Effects of the neurological wake-up test on intracranial pressure and cerebral perfusion pressure in brain-injured patients. Neurocritical care 2009; 11:135-142.
13. Shiue I, Arima H, Hankey GJ, Anderson CS. Location and size of ruptured intracranial aneurysm and serious clinical outcomes early after subarachnoid hemorrhage: a population-based study in Australasia. Cerebrovasc Dis 2011; 31:573-579.
14. Langham J, Reeves BC, Lindsay KW, et al. Variation in outcome after subarachnoid hemorrhage: a study of neurosurgical units in UK and Ireland. Stroke 2009; 40:111-118.
15. Hopf NJ, Fullbier L. Minimally invasive neurosurgery for vascular lesions. Neurosurg Clin N Am 2010; 21:673-689; vii.
16. Sakr YL, Lim N, Amaral AC, et al. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol 2004; 96:369-373. (Pubitemid 39099498)
17. Huang CC, Huang CH, Kuo HY, et al. The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: Early risk prognostication. Am J Emerg Med 2011; (in press).
18. Frontera JA, Parra A, Shimbo D, et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis 2008; 26:71-78. (Pubitemid 351931423)
19. Banki NM, Kopelnik A, Dae MW, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 2005; 112:3314-3319. (Pubitemid 43739377)
20. Vannemreddy P, Venkatesh P, Dinesh K, et al. Myocardial dysfunction in subarachnoid hemorrhage: prognostication by echo cardiography and cardiac enzymes. A prospective study. Acta Neurochir Suppl 2010; 106:151-154.
21. Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005; 112:2851-2856. (Pubitemid 41641680)
22. Jyotsna M, Prasad V, Indrani G, Trikamji BV. Importance of detection of segmental wall motion abnormalities of left ventricle in nontraumatic subarach noid hemorrhage: a prospective study. Echocardiography 2010; 27:496-500.
23. Temes RE, Tessitore E, Schmidt JM, et al. Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage. Neurocritical care 2010; 13:359-365.
24. Yousef K, Crago E, Kuo CW, et al. Predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a cardiac focus. Neurocritical care 2010; 13:366-372.
25. Kitamura Y, Nomura M, Shima H, et al. Acute lung injury associated with systemic inflammatory response syndrome following subarachnoid hemorrhage: a survey by the shonan neurosurgical association. Neurol Med Chir 2010; 50:456-460.
26. Stocchetti N. Wet lungs, broken hearts and difficult therapies after subarachnoid hemorrhage. Crit Care 2010; 14:140.
27. Chai TS, Charchaflieh J, Svyatets M. Pulmonary hypertension in a patient with subarachnoid hemorrhage. J Neurosurg Anesthesiol 2011; 23:264-265.
28. Sherlock M, O'Sullivan E, Agha A, et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2006; 64:250-254.
29. Kurokawa Y, Uede T, Ishiguro M, et al. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol 1996; 46:500-507; discussion 507-508.
30. Qureshi AI, Suri MF, Sung GY, et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2002; 50:749-755; discussion 755-746.
31. Naidech AM, Bendok BR, Bernstein RA, et al. Fever burden and functional recovery after subarachnoid hemorrhage. Neurosurgery 2008; 63:212-217; discussion 217-218.
32. Badjatia N, Fernandez L, Schmidt JM, et al. Impact of induced normothermia on outcome after subarachnoid hemorrhage: a case-control study. Neuro surgery 2010; 66:696-700; discussion 700-691.
33. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the multicenter cooperative aneurysm study. Crit Care Med 1995; 23:1007-1017.
34. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2005; 36:992-997. (Pubitemid 40629290)
35. Yin L, Ma CY, Li ZK, et al. Predictors analysis of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl 2011; 110 (Pt 2):175-178.
36. Friedman JA, Goerss SJ, Meyer FB, et al. Volumetric quantification of fisher grade 3 aneurysmal subarachnoid hemorrhage: a novel method to predict symptomatic vasospasm on admission computerized tomography scans. J Neurosurg 2002; 97:401-407. (Pubitemid 34827341)
37. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2011; 31:1443-1451.
38. Jun P, Ko NU, English JD, et al. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2010; 31:1911-1916.
39. Jordan JD, Nyquist P. Biomarkers and vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21:381-391.
40. Frontera JA, Fernandez A, Schmidt JM, et al. Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage. Neurosurgery 2010; 66:35-41; discussion 41.
41. Egge A, Waterloo K, Sjoholm H, et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001; 49:593-605; discussion 605-596.
42. Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000; 31:383-391. (Pubitemid 30078170)
43. Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 2007; 35:1844-1851; quiz 1852. (Pubitemid 47220357)
44. Rosenwasser RH, Armonda RA, Thomas JE, et al. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999; 44:975-979; discussion 979-980.
45. Barker FG, 2nd, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996; 84:405-414.
46. Kronvall E, Undren P, Romner B, et al. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. J Neurosurg 2009; 110:58-63.
47. Musahl C, Henkes H, Vajda Z, et al. Continuous local intra-arterial nimodipine-application (clina) in severe symptomatic vasospasm following subarachnoid hemorrhage. Neurosurgery 2011; 68:1541-1547.
48. Ehtisham A, Taylor S, Bayless L, et al. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. South Med J 2009; 102:150-153.
49. Suzuki M, Doi M, Otawara Y, et al. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev 2001; 24:180-184. (Pubitemid 34003132)
50. Westermaier T, Stetter C, Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med 2010; 38:1284-1290.
51. Wong GK, Boet R, Poon WS, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care 2011; 15:R52.
52. Wong GK, Poon WS, Chan MT, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (imash): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010; 41:921-926.
53. Malagos WT, Figueiredo EG. Do statins play a role after subarachnoid hemorrhage? World neurosurgery 2010; 74 (2-3):211-212.
54. Kramer AH. Statins in the management of aneurysmal subarachnoid hemorrhage: an overview of animal research, observational studies, randomized controlled trials and meta-analyses. Acta Neurochir Suppl 2011; 110 (Pt 2): 193-201.
55. Kramer AH, Fletcher JJ. Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit care 2010; 12:285-296.
56. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 2010; 41:e47-e52.
57. Sabri M, Macdonald RL. Statins: a potential therapeutic addition to treatment for aneurysmal subarachnoid hemorrhage? World neurosurg 2010; 73:646-653.
58. Takata K, Sheng H, Borel CO, et al. Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol 2009; 21:326-333.
59. Sampson TR, Dhar R, Diringer MN. Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit care 2010; 1 2:4-9.
60. Kurtz P, Schmidt JM, Claassen J, et al. Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. Neurocrit care 2010; 13:10-16.
61. Levine J, Kofke A, Cen L, et al. Red blood cell transfusion is associated with infection and extracerebral complications after subarachnoid hemorrhage. Neurosurgery 2010; 66:312-318; discussion 318.
62. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, american heart association. Stroke 2009; 40:994-1025.
63. Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase ii randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 2009; 111:171-1 80.
64. Turner JD, Mammis A, Prestigiacomo CJ. Erythropoietin for the treatment of subarachnoid hemorrhage: a review. World Neurosurg 2010; 73:500-507.
65. Grasso G, Sfacteria A. Erythropoietin and subarachnoid hemorrhage. J Neurosurg 2010; 112:699-700.
66. Riordan KC, Wingerchuk DM, Wellik KE, et al. Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: a critically appraised topic. Neurologist 2010; 16:397-399.
67. Usami K, Saito N. Prophylactic anticonvulsants after subarachnoid hemorrhage. World Neurosurg 2011; 75:214.
68. Gilmore E, Choi HA, Hirsch LJ, Claassen J. Seizures and cns hemorrhage: spontaneous intracerebral and aneurysmal subarachnoid hemorrhage. Neurologist 2010; 16:165-175.
69. Chwajol M, Starke RM, Kim GH, et al. Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage. Neurocrit care 2008; 8:418-426.
70. Starke RM, Kim GH, Fernandez A, et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke 2008; 39:2617-2621.
71. Harrigan MR, Rajneesh KF, Ardelt AA, Fisher WS, 3rd. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery 2010; 67:935-939; discussion 939-940.